Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 5, 2012, Pages 739-745

  Campanile, F ^a   Bongiorno, D ^a   Falcone, M ^b   Vailati, F ^e   Pasticci, M B ^d   Perez, M ^a   Raglio, A ^e   Rumpianesi, F ^c   Scuderi, C ^a   Suter, F ^e   Venditti, M ^b   Venturelli, C ^c   Ravasio, V ^e   Codeluppi, M ^c   Stefani, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLONE; COMMUNICABLE DISEASE; CONTROLLED STUDY; GENOTYPE; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; ITALY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PVL GENE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CLUSTER ANALYSIS; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; GENOTYPE; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 84862844384     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1367-y     Document Type: Article

References (33)

1. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288 (1):75-81
2. Chi C, Wang SM, Lin CC, Liu CC (2010) Microbiological characteristics of community-associated Staphylococcus aureus causing uncomplicated bacteremia and infective endocarditis. J Clin Microbiol 48 (1):292-294
3. Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM (2006) Effects of prolonged vancomycin administration on methicillin- resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother 57 (4):699-704
4. Sader HS, Jones RN, Rossi KL, Rybak MJ (2009) Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. J Antimicrob Chemother 64 (5):1024-1028
5. Wang JL, Wang JT, Sheng WH, Chen YC, Chang SC (2010) Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method. BMC Infect Dis 10:159-165
6. Bae IG, Federspiel JJ, Miró JM, Woods CW, Park L, Rybak MJ, Rude TH, Bradley S, Bukovski S, de la Maria CG, Kanj SS, Korman TM, Marco F, Murdoch DR, Plesiat P, Rodriguez- Creixems M, Reinbott P, Steed L, Tattevin P, Tripodi MF, Newton KL, Corey GR, Fowler VG (2009) Heterogeneous vancomycinintermediate susceptibility phenotype in bloodstream methicillinresistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. J Infect Dis 200 (9):1355-1366
7. Entenza JM, Veloso TR, Vouillamoz J, Giddey M,Moreillon P (2011) Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 55 (1):385-387
8. Moise PA, Smyth DS, Robinson DA, El-Fawal N, McCalla C, Sakoulas G (2009) Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies. J Antimicrob Chemother 63 (5):873-876
9. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (24):3012-3021
10. Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG (2005) A comparison of clinical features and mortality among methicillinresistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 46 (4):496-502
11. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 82 (5):322-332
12. Hill EE, Peetermans WE, Vanderschueren S, Claus P, Herregods MC, Herijgers P (2008) Methicillin-resistant versus methicillinsensitive Staphylococcus aureus infective endocarditis. Eur J Clin Microbiol Infect Dis 27 (6):445-450
13. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (4):633-638
14. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36 (5):309-332
15. Clinical and Laboratory Standard Institutes (2011) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement M100-S21. CLSI, Wayne, PA, USA 16. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Clinical Breakpoints (2011) http://www.eucast. org/clinical-breakpoints (Accessed 5 May 2011)
16. Campanile F, Bongiorno D, Borbone S, Stefani S (2009) Hospitalassociated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy. Ann Clin Microbiol Antimicrob 8:22-31
17. Campanile F, Borbone S, Perez M, Bongiorno D, Cafiso V, Bertuccio T, Purrello S, Nicolosi D, Scuderi C, Stefani S (2010) Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates. Int J Antimicrob Agents 36 (5):415-419
18. Campanile F, Bongiorno D, Borbone S, Stefani S (2010) Methicillin-resistant Staphylococcus aureus (MRSA) evolution: the multiple facets of an old pathogen. Eur Infect Dis 4 (1):70-76
19. Vidal PM, Trindade PA, Garcia TO, Pacheco RL, Costa SF, Reinert C, Hiramatsu K, Mamizuka EM, Garcia CP, Levin AS (2009) Differences between "classical" risk factors for infections caused by methicillin- resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain. Infect Control Hosp Epidemiol 30 (2):139-145
20. Valsesia G, Rossi M, Bertschy S, Pfyffe GE (2010) Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: external invaders or persisting circulators? J Clin Microbiol 48 (3):720-727
21. BassettiM, Nicco E, Malgorzata M,Viscoli C,ValbusaA, Bongiorno D, Campanile F, Stefani S (2010) Community associated methicillin resistant Staphylococcus aureus (CA-MRSA) infective endocarditis in Italy. J Infect 61 (4):353-355
22. Okon KO, Basset P, Uba A, Lin J, Oyawoye B, Shittu AO, Blanc DS (2009) Cooccurrence of predominant Panton-Valentine leukocidin-positive sequence type (ST) 152 and multidrugresistant ST 241 Staphylococcus aureus clones in Nigerian hospitals. J Clin Microbiol 47 (9):3000-3003
23. Pérez-Roth E, Alcoba-Flórez J, López-Aguilar C, Gutiérrez- González I, Rivero-Pérez B, Méndez- Alvarez S (2010) Familial furunculosis associated with community-acquired leukocidinpositive methicillin-susceptible Staphylococcus aureus ST152. J Clin Microbiol 48 (1):329-332
24. Borbone S, Campanile F, Bongiorno D, Stefani S (2010) In vitro bactericidal activity of ceftobiprole against hospital- and communityassociatedmethicillin- resistant Staphylococcus aureus. J Antimicrob Chemother 65 (3):591-594
25. Sanchini A, Campanile F, Monaco M, Cafiso V, Rasigade JP, Laurent F, Etienne J, Stefani S, Pantosti A (2011) DNA microarray-based characterization of Panton-Valentine leukocidinpositive community-acquired methicillin-resistant Staphylococcus aureus from Italy. Eur J Clin Microbiol Infect Dis 10.1007/s10096-011-1234-x
26. Wang CC, Lo WT, Chu ML, Siu LK (2004) Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 39 (4):481-487
27. Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul H, Bouvet A, Pocidalo JJ, Carbon C (1989) Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis 159 (5):938-944
28. Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW (2009) Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis 49 (8):1169-1174
29. Naimi TS, Anderson D, O'Boyle C, Boxrud DJ, Johnson SK, Tenover FC, Lynfield R (2003) Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Clin Infect Dis 36 (12):1609-1612
30. Hageman JC, Pegues DA, Jepson C, Bell RL, Guinan M, Ward KW, Cohen MD, Hindler JA, Tenover FC, McAllister SK, Kellum ME, Fridkin SK (2001) Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. Emerg Infect Dis 7 (6):1023-1025
31. Bobin-Dubreux S, Reverdy ME, Nervi C, Rougier M, Bolmström A, Vandenesch F, Etienne J (2001) Clinical isolate of vancomycinheterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob Agents Chemother 45 (1):349-352
32. Rasigade JP, Laurent F, Lina G, Meugnier H, Bes M, Vandenesch F, Etienne J, Tristan A (2010) Global distribution and evolution of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus, 1981-2007. J Infect Dis 201 (10):1589-1597
33. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40:4289-4294